Black Market Retatrutide Linked to Multiple Deaths

The FDA has received at least two reports of deaths tied to bootleg retatrutide, an experimental Eli Lilly weight-loss drug that has not completed clinical trials. One case involves a 41-year-old obese woman who died of cardiac arrest in July after obtaining the drug from an unreliable source.

• FDA has reports of two deaths linked to bootleg retatrutide
• A 41-year-old woman died of cardiac arrest in July 2026
• April case involved overdose with kidney injury and diarrhea
• Eli Lilly's retatrutide has not completed clinical trials